Suppr超能文献

在阿尔茨海默病的临床和病理进展过程中,皮质默认模式网络中的囊泡谷氨酸转运体变化。

Vesicular Glutamate Transporter Changes in the Cortical Default Mode Network During the Clinical and Pathological Progression of Alzheimer's Disease.

机构信息

Department of Neurology, University of Pittsburgh School of Medicine, Pittsburgh, PA, USA.

Geriatric Research Education and Clinical Center, VA Pittsburgh Healthcare System, Pittsburgh, PA, USA.

出版信息

J Alzheimers Dis. 2023;94(1):227-246. doi: 10.3233/JAD-221063.

Abstract

BACKGROUND

Altered glutamatergic neurotransmission may contribute to impaired default mode network (DMN) function in Alzheimer's disease (AD). Among the DMN hub regions, frontal cortex (FC) was suggested to undergo a glutamatergic plasticity response in prodromal AD, while the status of glutamatergic synapses in the precuneus (PreC) during clinical-neuropathological AD progression is not known.

OBJECTIVE

To quantify vesicular glutamate transporter VGluT1- and VGluT2-containing synaptic terminals in PreC and FC across clinical stages of AD.

METHODS

Unbiased sampling and quantitative confocal immunofluorescence of cortical VGluT1- and VGluT2-immunoreactive profiles and spinophilin-labeled dendritic spines were performed in cases with no cognitive impairment (NCI), mild cognitive impairment (MCI), mild-moderate AD (mAD), or moderate-severe AD (sAD).

RESULTS

In both regions, loss of VGluT1-positive profile density was seen in sAD compared to NCI, MCI, and mAD. VGluT1-positive profile intensity in PreC did not differ across groups, while in FC it was greater in MCI, mAD, and sAD compared to NCI. VGluT2 measures were stable in PreC while FC had greater VGluT2-positive profile density in MCI compared to sAD, but not NCI or mAD. Spinophilin measures in PreC were lower in mAD and sAD compared to NCI, while in FC they were stable across groups. Lower VGluT1 and spinophilin measures in PreC, but not FC, correlated with greater neuropathology.

CONCLUSION

Frank loss of VGluT1 in advanced AD relative to NCI occurs in both DMN regions. In FC, an upregulation of VGluT1 protein content in remaining glutamatergic terminals may contribute to this region's plasticity response in AD.

摘要

背景

谷氨酸能神经传递的改变可能导致阿尔茨海默病(AD)中默认模式网络(DMN)功能受损。在 DMN 枢纽区域中,额叶皮层(FC)在 AD 前驱期被认为经历了谷氨酸能可塑性反应,而在临床-神经病理学 AD 进展过程中,楔前叶(PreC)的谷氨酸能突触状态尚不清楚。

目的

定量 AD 各临床阶段 PreC 和 FC 中囊泡谷氨酸转运体 VGluT1 和 VGluT2 包含的突触末端。

方法

在无认知障碍(NCI)、轻度认知障碍(MCI)、轻度中度 AD(mAD)或中度重度 AD(sAD)病例中,进行皮质 VGluT1 和 VGluT2 免疫反应性轮廓和 spinophilin 标记的树突棘的无偏采样和定量共聚焦免疫荧光。

结果

在两个区域,sAD 中 VGluT1 阳性轮廓密度的丧失均高于 NCI、MCI 和 mAD。PreC 中 VGluT1 阳性轮廓强度在各组之间没有差异,而在 FC 中,MCI、mAD 和 sAD 均高于 NCI。在 PreC 中 VGluT2 测量值稳定,而在 FC 中,MCI 中 VGluT2 阳性轮廓密度高于 sAD,但低于 NCI 或 mAD。PreC 中的 spinophilin 测量值在 mAD 和 sAD 中低于 NCI,而在 FC 中各组之间稳定。PreC 中较低的 VGluT1 和 spinophilin 测量值与较大的神经病理学相关,而在 FC 中则与各组无相关性。

结论

与 NCI 相比,AD 晚期 FC 和 DMN 两个区域中均出现 VGluT1 的明显丧失。在 FC 中,剩余谷氨酸能末梢中 VGluT1 蛋白含量的上调可能导致该区域在 AD 中的可塑性反应。

相似文献

3
Loss of precuneus dendritic spines immunopositive for spinophilin is related to cognitive impairment in early Alzheimer's disease.
Neurobiol Aging. 2017 Jul;55:159-166. doi: 10.1016/j.neurobiolaging.2017.01.022. Epub 2017 Feb 4.
4
Developmental up-regulation of vesicular glutamate transporter-1 promotes neocortical presynaptic terminal development.
PLoS One. 2012;7(11):e50911. doi: 10.1371/journal.pone.0050911. Epub 2012 Nov 30.
5
Telomeric alterations in the default mode network during the progression of Alzheimer's disease: Selective vulnerability of the precuneus.
Neuropathol Appl Neurobiol. 2021 Apr;47(3):428-440. doi: 10.1111/nan.12672. Epub 2020 Dec 5.
8
Loss of VGLUT1 and VGLUT2 in the prefrontal cortex is correlated with cognitive decline in Alzheimer disease.
Neurobiol Aging. 2008 Nov;29(11):1619-30. doi: 10.1016/j.neurobiolaging.2007.04.010. Epub 2007 May 24.

引用本文的文献

1
NMDA receptors in neurodegenerative diseases: mechanisms and emerging therapeutic strategies.
Front Aging Neurosci. 2025 Jul 24;17:1604378. doi: 10.3389/fnagi.2025.1604378. eCollection 2025.
2
Excitatory neuron-prone prion propagation and excitatory neuronal loss in prion-infected mice.
Front Mol Neurosci. 2024 Dec 12;17:1498142. doi: 10.3389/fnmol.2024.1498142. eCollection 2024.
3
Synergistic effects of plasma-activated medium in combination with Baicalin against neuronal damage.
Heliyon. 2024 Aug 11;10(16):e36079. doi: 10.1016/j.heliyon.2024.e36079. eCollection 2024 Aug 30.
4
Application of robust regression in translational neuroscience studies with non-Gaussian outcome data.
Front Aging Neurosci. 2024 Jan 24;15:1299451. doi: 10.3389/fnagi.2023.1299451. eCollection 2023.
5
Glaucoma Animal Models beyond Chronic IOP Increase.
Int J Mol Sci. 2024 Jan 11;25(2):906. doi: 10.3390/ijms25020906.

本文引用的文献

1
Neuropathology of Dementia Disorders.
Continuum (Minneap Minn). 2022 Jun 1;28(3):834-851. doi: 10.1212/CON.0000000000001137.
2
Recent update on the heterogeneity of the Alzheimer's disease spectrum.
J Neural Transm (Vienna). 2022 Jan;129(1):1-24. doi: 10.1007/s00702-021-02449-2. Epub 2021 Dec 17.
3
Postmortem Neocortical H-PiB Binding and Levels of Unmodified and Pyroglutamate Aβ in Down Syndrome and Sporadic Alzheimer's Disease.
Front Aging Neurosci. 2021 Aug 13;13:728739. doi: 10.3389/fnagi.2021.728739. eCollection 2021.
5
What is 'Alzheimer's disease'? The neuropathological heterogeneity of clinically defined Alzheimer's dementia.
Curr Opin Neurol. 2021 Apr 1;34(2):237-245. doi: 10.1097/WCO.0000000000000912.
6
The development and convergence of co-pathologies in Alzheimer's disease.
Brain. 2021 Apr 12;144(3):953-962. doi: 10.1093/brain/awaa438.
7
Post-mortem analyses of PiB and flutemetamol in diffuse and cored amyloid-β plaques in Alzheimer's disease.
Acta Neuropathol. 2020 Oct;140(4):463-476. doi: 10.1007/s00401-020-02175-1. Epub 2020 Aug 9.
8
Research progress on the role of type I vesicular glutamate transporter (VGLUT1) in nervous system diseases.
Cell Biosci. 2020 Mar 4;10:26. doi: 10.1186/s13578-020-00393-4. eCollection 2020.
9
Neuropathological correlates of amyloid PET imaging in Down syndrome.
Dev Neurobiol. 2019 Jul;79(7):750-766. doi: 10.1002/dneu.22713. Epub 2019 Aug 17.
10
The neuropathological diagnosis of Alzheimer's disease.
Mol Neurodegener. 2019 Aug 2;14(1):32. doi: 10.1186/s13024-019-0333-5.

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验